345 related articles for article (PubMed ID: 25278685)
1. Problems faced by evidence-based medicine in evaluating lymphadenectomy for gastric cancer.
Verlato G; Giacopuzzi S; Bencivenga M; Morgagni P; De Manzoni G
World J Gastroenterol; 2014 Sep; 20(36):12883-91. PubMed ID: 25278685
[TBL] [Abstract][Full Text] [Related]
2. Gastric cancer: Current status of lymph node dissection.
Degiuli M; De Manzoni G; Di Leo A; D'Ugo D; Galasso E; Marrelli D; Petrioli R; Polom K; Roviello F; Santullo F; Morino M
World J Gastroenterol; 2016 Mar; 22(10):2875-93. PubMed ID: 26973384
[TBL] [Abstract][Full Text] [Related]
3. D2 dissection improves disease-specific survival in advanced gastric cancer patients: 15-year follow-up results of the Italian Gastric Cancer Study Group D1 versus D2 randomised controlled trial.
Degiuli M; Reddavid R; Tomatis M; Ponti A; Morino M; Sasako M;
Eur J Cancer; 2021 Jun; 150():10-22. PubMed ID: 33887514
[TBL] [Abstract][Full Text] [Related]
4. Do all the European surgeons perform the same D2? The need of D2 audit in Europe.
Bencivenga M; Verlato G; Mengardo V; Weindelmayer J; Allum WH
Updates Surg; 2018 Jun; 70(2):189-195. PubMed ID: 29869322
[TBL] [Abstract][Full Text] [Related]
5. Nationwide study of the impact of D2 lymphadenectomy on survival after gastric cancer surgery.
Kung CH; Tsai JA; Lundell L; Johansson J; Nilsson M; Lindblad M
BJS Open; 2020 Jun; 4(3):424-431. PubMed ID: 32129948
[TBL] [Abstract][Full Text] [Related]
6. Resection for gastric cancer in the community.
van de Velde CJ
Semin Oncol; 2005 Dec; 32(6 Suppl 9):S90-3. PubMed ID: 16399441
[TBL] [Abstract][Full Text] [Related]
7. Survival prognosis and clinicopathological features of the lymph nodes along the left gastric artery in gastric cancer: implications for D2 lymphadenectomy.
Chen JH; Cai SR; Zhai ET; Chen SL; Wu KM; Song W; He YL
Int J Clin Exp Pathol; 2015; 8(11):14365-73. PubMed ID: 26823752
[TBL] [Abstract][Full Text] [Related]
8. [Total gastrectomy for gastric cancer: can the type of lymphadenectomy condition the long-term results?].
Di Martino N; Izzo G; Cosenza A; Vicenzo L; Monaco L; Torelli F; Basciotti A; Brillantino A; Marra A
Suppl Tumori; 2005; 4(3):S84-5. PubMed ID: 16437920
[TBL] [Abstract][Full Text] [Related]
9. Current role of lymphadenectomy in gastric cancer surgery.
Symeonidis D; Diamantis A; Bompou E; Tepetes K
J BUON; 2019; 24(5):1761-1767. PubMed ID: 31786835
[TBL] [Abstract][Full Text] [Related]
10. Quality control of lymph node dissection in the Dutch Gastric Cancer Trial.
de Steur WO; Hartgrink HH; Dikken JL; Putter H; van de Velde CJ
Br J Surg; 2015 Oct; 102(11):1388-93. PubMed ID: 26313463
[TBL] [Abstract][Full Text] [Related]
11. Extended lymphadenectomy in gastric cancer is debatable.
Strong VE; Yoon SS
World J Surg; 2013 Aug; 37(8):1773-7. PubMed ID: 23649527
[TBL] [Abstract][Full Text] [Related]
12. Compliance to D2 lymphadenectomy in laparoscopic gastrectomy.
Eshuis WJ; van Berge Henegouwen MI; Draaisma WA; Gisbertz SS
Updates Surg; 2018 Jun; 70(2):197-205. PubMed ID: 29926307
[TBL] [Abstract][Full Text] [Related]
13. Prospective randomized controlled trial to compare laparoscopic distal gastrectomy (D2 lymphadenectomy plus complete mesogastrium excision, D2 + CME) with conventional D2 lymphadenectomy for locally advanced gastric adenocarcinoma: study protocol for a randomized controlled trial.
Shen J; Cao B; Wang Y; Xiao A; Qin J; Wu J; Yan Q; Hu Y; Yang C; Cao Z; Hu J; Yin P; Xie D; Gong J
Trials; 2018 Aug; 19(1):432. PubMed ID: 30092843
[TBL] [Abstract][Full Text] [Related]
14. Current standards of lymphadenectomy in gastric cancer.
Monrabal Lezama M; Murdoch Duncan NS; Bertona S; Schlottmann F
Updates Surg; 2023 Oct; 75(7):1751-1758. PubMed ID: 37358724
[TBL] [Abstract][Full Text] [Related]
15. Lymph node dissection in resectable advanced gastric cancer.
de Steur WO; Dikken JL; Hartgrink HH
Dig Surg; 2013; 30(2):96-103. PubMed ID: 23867585
[TBL] [Abstract][Full Text] [Related]
16. Modified radical lymphadenectomy (D1.5) for T2-3 gastric cancer.
Ichikura T; Chochi K; Sugasawa H; Mochizuki H
Langenbecks Arch Surg; 2005 Sep; 390(5):397-402. PubMed ID: 16041552
[TBL] [Abstract][Full Text] [Related]
17. Standardization of D2 lymphadenectomy and surgical quality control (KLASS-02-QC): a prospective, observational, multicenter study [NCT01283893].
Kim HI; Hur H; Kim YN; Lee HJ; Kim MC; Han SU; Hyung WJ
BMC Cancer; 2014 Mar; 14():209. PubMed ID: 24646327
[TBL] [Abstract][Full Text] [Related]
18. The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma.
Volpe CM; Koo J; Miloro SM; Driscoll DL; Nava HR; Douglass HO
J Am Coll Surg; 1995 Jul; 181(1):56-64. PubMed ID: 7599772
[TBL] [Abstract][Full Text] [Related]
19. Lymphadenectomy extent and survival of patients with gastric carcinoma: a systematic review and meta-analysis of time-to-event data from randomized trials.
Mocellin S; Nitti D
Cancer Treat Rev; 2015 May; 41(5):448-54. PubMed ID: 25814393
[TBL] [Abstract][Full Text] [Related]
20. [Comparative study of D1 and D2 ganglionic dissection in advanced gastric cancer at Rebagliati Hospital].
Cornejo C; Portanova M
Rev Gastroenterol Peru; 2006; 26(4):351-6. PubMed ID: 17211484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
